
Tumor Models Boston Summit
Join us at the 12th Annual Tumor Models Boston Summit.
WuXi Biology offers an integrated package of preclinical cancer pharmacology services for targeted oncology and immuno-oncology. Our platform includes in vitro cell-free and cell-based assays, a comprehensive panel of in vivo tumor models, and multidisciplinary ex vivo PD analysis services.
To view our latest brochure showcasing our comprehensive platform of cancer pharmacology services, and to read about our case study evaluating a KRAS G12C inhibitor click HERE.
We have pioneered the development of over 1,500 PDX models across 30 cancer types, encompassing both prevalent and rare indications for solid and hematological malignancies. We also offer comprehensive biomarker discovery support, utilizing a broad range of advanced technologies for both single and multiplex assay platforms.
To schedule a dedicated meeting, please complete the brief form on the right.
Resource Links
Cancer Pharmacology Services
Resource Type: Brochure
Expanded Role of PDX Models in Anticancer Drug Development
Resource Type: Latest Science
WuXi AppTec Discovery Services
Resource Type: Brochure